Place of Origin: | China |
---|---|
Brand Name: | HNB |
Certification: | ISO |
Model Number: | Diacereine |
Minimum Order Quantity: | 1KG |
Price: | Negotiable |
Packaging Details: | Aluminum foil bag |
Delivery Time: | Usually3-5days |
Payment Terms: | L/C, D/A, D/P, T/T, , MoneyGram,Alibaba Assurance Order |
Supply Ability: | 5000kg/Month |
CAS: | 13739-02-1 | Mf: | C19H12O8 |
---|---|---|---|
MW: | 368.2938 | Specification: | 99% |
Melting Point: | 231.76ºC | Appearance: | Light Yellow Powder |
Sample: | Available | ||
High Light: | 99% Diacerein Powder,Degenerative Joint Disease Diacerein Powder |
Antipyretic Analgesic 99% Diacereine Powder CAS 13739-02-1 For Degenerative Joint Disease
Product name |
Diacereine |
Appearance |
Light yellow powder |
CAS |
13739-02-1 |
MF |
C19H12O8 |
Purity |
99% |
Storage |
Keep in cool dry place. |
The Introductction of Diacereine :
Diacethane, C19H12O8, is an important inhibitor of IL-1 in osteoarthritis. Diacreine, also known as diacetyldihydroanthracene carboxylic acid, 1, 8-diacetyl-3-carboxyanthraquinone, daceridine, and ambitin, is a new interleukin (IL) -1 inhibitor, chemical name is diacetylrhein, belongs to the anthraquinone compound.
The Application & Function of Diacereine :
this product can induce chondrogenesis, has analgesic, anti-inflammatory and antipyretic effects, and can also significantly improve the joint function of osteoarthritis patients. Delay the course of the disease, reduce pain, improve the quality of life of patients, with good safety, clinical mainly used in the treatment of osteoarthritis (OA) and play an antibacterial role.
It is the primary inhibitor of IL-1 in osteoarthritis. It has been confirmed by cell experiment and animal experiment that:
(1) this product can induce chondrogenesis, have analgesic, anti-inflammatory and antipyretic effects;
(2) do not inhibit prostaglandin synthesis;
(3) It can delay the disease process of osteoarthritis;
(4) Inhibit the production of metalloproteinases and peroxides such as collagenase and stromatolysin;
(5) Promote the synthesis of collagen and aminoglycan;
(6) Inhibit the chemotaxis of leukocytes and stabilize lysosomes. At present, this drug is mainly used to treat osteoarthritis, and it is likely to have a therapeutic effect on rheumatoid arthritis.
Other Name of Diacereine :
DIACETYL RHEIN; DIACEREIN; 4,5-Diacetoxyanthraquinone-2-carboxylic Acid; SF 277; Diacereine;1,8-Diacetoxy-3-carboxyanthraquinone
The COA of Diacereine :
Product Name | Diacereine | Batch No. | HNB-190302 |
Quantity | 100kg | Test Sample | 10g |
Manuf.Date | 2022.12.02 | Test Date | 2022.12.02 |
Issuing Date | 2022.12.02 | Expiry Date | 2024.12.01 |
Test parameter | Test Iimit | Results | |
Appearance | Yellow to light yellow crystalline powder | Light yellow crystalline Powder | |
Identification | A: IR | Conforms | |
B: HPLC | Conforms | ||
Solubility | It is soluble in dimethylformamide, very slightly soluble in methanol or ethanol, and almost insoluble in water. | Conforms | |
Assay | ≥98.5% | 99.85% | |
Choride | ≤ 0.1% | 0.03% | |
pH | 7.0~8.5 | 7.26 | |
Related Substances | Individual impurity: ≤0.5% | Conforms | |
Total impurties: ≤1.0% | Conforms | ||
Solvent residue | Ethanol, N,N-dimethylformamide, tetrahydrofuran, methylene chloride, toluene and xylene residues should be conformed with the specification | Conforms | |
Residue on Ignition | ≤0.1% | 0.019% | |
Heavy metals | ≤10ppm | Conforms | |
As | ≤ 2ppm | Conforms | |
Loss on drying | ≤0.5% | 0.2% | |
Conclusion | The above material complies with USP 34 standard |